Andy
Retired committee member
I've taken the title of this thread from the draft NICE guideline for ME/CFS, where it highlights the topic as one where research is required, and I thought it would be a good subject for general discussion.
It's been suggested to that the ACR (American College of Rheumatology) score may be a good model.
ACR Score: How Do You Measure Rheumatoid Arthritis with ACR Scores?
The ACR score has a primary measure of, I assume self-reported, improvement in tender and painful joints, as well as five other parameters:
All quotes from https://www.rheumatoidarthritis.org/treatment/acr-score/
So, if we were to have something similar for ME, what measures and parameters would we want to see used.
It's been suggested to that the ACR (American College of Rheumatology) score may be a good model.
ACR Score: How Do You Measure Rheumatoid Arthritis with ACR Scores?
The ACR scoring system, named after the American College of Rheumatology, helps physicians to measure the amount of improvement in their patients’ rheumatoid arthritis after being treated with various medications. In other words, the ACR score measures the efficacy of certain treatments for rheumatoid arthritis. The initial ACR system developed is the ACR20, which measures a twenty percent improvement in the patient’s reported pain scale and swelling in designated joints. Later on, ACR50 and ACR70 were also adopted to respectively indicate a fifty or seventy percent improvement in patients’ rheumatoid arthritis symptoms.
The ACR score has a primary measure of, I assume self-reported, improvement in tender and painful joints, as well as five other parameters:
- Inflammation
- Patient assessment
- Physician assessment
- Pain scale
- Disability/functionality questionnaire
If a patient were to receive a score of ACR 20, that means that that patient has improved their tender and painful joint counts by 20 percent, as well as made a 20 percent improvement in three of the five above parameters.
ACR scores are most often used in the context of clinical trials rather than between physicians and patients. The most prominent purpose of the score was to standardize measures of improvement in clinical trials so that different clinical trials of treatments and medications would be more easily compared and evaluated. The US Food and Drug Administration has also recognized the ACR20 as a preferred method of evaluating the efficacy of a new drug in improving the signs, symptoms, and complications of rheumatoid arthritis.
All quotes from https://www.rheumatoidarthritis.org/treatment/acr-score/
So, if we were to have something similar for ME, what measures and parameters would we want to see used.